谷氨酰胺颗粒对重度慢性乙型病毒性肝炎患者肠道通透性、内毒素血症与肝功能的影响

表2 对照组与治疗组治疗前后肝功能、ET、L/M差值变化 (n = 30, mean±SD)

	ALT(U)	TBIL(Umol/L)	CHE(U)	ET(EU/mL)	L/M
对照组	199.65±127.09	94.13±172.67	-892.23±861.41	0.055±0.057	0.0089±0.0228
治疗组	281.86±149.34a	168.65±102.04b	-1301.04±662.78c	0.093±0.066d	0.0198±0.0128e

t = 2.296,

^aP = 0.025; t = 2.035,

^bP = 0.046; t = 2.010,

^cP = 0.044; t = 2.412,

^dP<0.019; t = 2.300,

^eP = 0.025.